Pharmacogenomics in the curricula of colleges and schools of pharmacy in the United States

John E Murphy, James S. Green, Laura A. Adams, Robert B. Squire, Grace M. Kuo, Alan Mckay

Research output: Contribution to journalArticle

81 Citations (Scopus)

Abstract

Objectives. To assess the breadth, depth, and perceived importance of pharmacogenomics instruction and level of faculty development in this area in schools and colleges of pharmacy in the United States. Methods. A questionnaire used and published previously was further developed and sent to individuals at all US schools and colleges of pharmacy. Multiple approaches were used to enhance response. Results. Seventy-five (83.3%) questionnaires were returned. Sixty-nine colleges (89.3%) included pharmacogenomics in their PharmD curriculum compared to 16 (39.0%) as reported in a 2005 study. Topic coverage was < 10 hours for 28 (40.6%), 10-30 hours for 29 (42.0%), and 31-60 hours for 10 (14.5%) colleges and schools of pharmacy. Fewer than half (46.7%) were planning to increase course work over the next 3 years and 54.7% had no plans for faculty development related to pharmacoge- nomics. Conclusions. Most US colleges of pharmacy include pharmacogenomics content in their curriculum, however, the depth may be limited. The majority did not have plans for faculty development in the area of pharmacogenomic content expertise.

Original languageEnglish (US)
Pages (from-to)7
Number of pages1
JournalAmerican Journal of Pharmaceutical Education
Volume74
Issue number1
StatePublished - 2010

Fingerprint

Pharmacy Schools
Pharmacogenetics
Curriculum
curriculum
school
questionnaire
expertise
coverage
instruction
planning

Keywords

  • Curriculum
  • Pharmacogenetics education
  • Pharmacogenomics education

ASJC Scopus subject areas

  • Pharmacology, Toxicology and Pharmaceutics(all)
  • Education

Cite this

Pharmacogenomics in the curricula of colleges and schools of pharmacy in the United States. / Murphy, John E; Green, James S.; Adams, Laura A.; Squire, Robert B.; Kuo, Grace M.; Mckay, Alan.

In: American Journal of Pharmaceutical Education, Vol. 74, No. 1, 2010, p. 7.

Research output: Contribution to journalArticle

Murphy, John E ; Green, James S. ; Adams, Laura A. ; Squire, Robert B. ; Kuo, Grace M. ; Mckay, Alan. / Pharmacogenomics in the curricula of colleges and schools of pharmacy in the United States. In: American Journal of Pharmaceutical Education. 2010 ; Vol. 74, No. 1. pp. 7.
@article{34e9845227b6405a8a5d692c7e1c1be7,
title = "Pharmacogenomics in the curricula of colleges and schools of pharmacy in the United States",
abstract = "Objectives. To assess the breadth, depth, and perceived importance of pharmacogenomics instruction and level of faculty development in this area in schools and colleges of pharmacy in the United States. Methods. A questionnaire used and published previously was further developed and sent to individuals at all US schools and colleges of pharmacy. Multiple approaches were used to enhance response. Results. Seventy-five (83.3{\%}) questionnaires were returned. Sixty-nine colleges (89.3{\%}) included pharmacogenomics in their PharmD curriculum compared to 16 (39.0{\%}) as reported in a 2005 study. Topic coverage was < 10 hours for 28 (40.6{\%}), 10-30 hours for 29 (42.0{\%}), and 31-60 hours for 10 (14.5{\%}) colleges and schools of pharmacy. Fewer than half (46.7{\%}) were planning to increase course work over the next 3 years and 54.7{\%} had no plans for faculty development related to pharmacoge- nomics. Conclusions. Most US colleges of pharmacy include pharmacogenomics content in their curriculum, however, the depth may be limited. The majority did not have plans for faculty development in the area of pharmacogenomic content expertise.",
keywords = "Curriculum, Pharmacogenetics education, Pharmacogenomics education",
author = "Murphy, {John E} and Green, {James S.} and Adams, {Laura A.} and Squire, {Robert B.} and Kuo, {Grace M.} and Alan Mckay",
year = "2010",
language = "English (US)",
volume = "74",
pages = "7",
journal = "American Journal of Pharmaceutical Education",
issn = "0002-9459",
publisher = "American Association of Colleges of Pharmacy",
number = "1",

}

TY - JOUR

T1 - Pharmacogenomics in the curricula of colleges and schools of pharmacy in the United States

AU - Murphy, John E

AU - Green, James S.

AU - Adams, Laura A.

AU - Squire, Robert B.

AU - Kuo, Grace M.

AU - Mckay, Alan

PY - 2010

Y1 - 2010

N2 - Objectives. To assess the breadth, depth, and perceived importance of pharmacogenomics instruction and level of faculty development in this area in schools and colleges of pharmacy in the United States. Methods. A questionnaire used and published previously was further developed and sent to individuals at all US schools and colleges of pharmacy. Multiple approaches were used to enhance response. Results. Seventy-five (83.3%) questionnaires were returned. Sixty-nine colleges (89.3%) included pharmacogenomics in their PharmD curriculum compared to 16 (39.0%) as reported in a 2005 study. Topic coverage was < 10 hours for 28 (40.6%), 10-30 hours for 29 (42.0%), and 31-60 hours for 10 (14.5%) colleges and schools of pharmacy. Fewer than half (46.7%) were planning to increase course work over the next 3 years and 54.7% had no plans for faculty development related to pharmacoge- nomics. Conclusions. Most US colleges of pharmacy include pharmacogenomics content in their curriculum, however, the depth may be limited. The majority did not have plans for faculty development in the area of pharmacogenomic content expertise.

AB - Objectives. To assess the breadth, depth, and perceived importance of pharmacogenomics instruction and level of faculty development in this area in schools and colleges of pharmacy in the United States. Methods. A questionnaire used and published previously was further developed and sent to individuals at all US schools and colleges of pharmacy. Multiple approaches were used to enhance response. Results. Seventy-five (83.3%) questionnaires were returned. Sixty-nine colleges (89.3%) included pharmacogenomics in their PharmD curriculum compared to 16 (39.0%) as reported in a 2005 study. Topic coverage was < 10 hours for 28 (40.6%), 10-30 hours for 29 (42.0%), and 31-60 hours for 10 (14.5%) colleges and schools of pharmacy. Fewer than half (46.7%) were planning to increase course work over the next 3 years and 54.7% had no plans for faculty development related to pharmacoge- nomics. Conclusions. Most US colleges of pharmacy include pharmacogenomics content in their curriculum, however, the depth may be limited. The majority did not have plans for faculty development in the area of pharmacogenomic content expertise.

KW - Curriculum

KW - Pharmacogenetics education

KW - Pharmacogenomics education

UR - http://www.scopus.com/inward/record.url?scp=77649120617&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77649120617&partnerID=8YFLogxK

M3 - Article

C2 - 20221358

AN - SCOPUS:77649120617

VL - 74

SP - 7

JO - American Journal of Pharmaceutical Education

JF - American Journal of Pharmaceutical Education

SN - 0002-9459

IS - 1

ER -